Insider Transactions in Q2 2025 at Arrowhead Pharmaceuticals, Inc. (ARWR)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 11
2025
|
Christopher Richard Anzalone Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,800
-1.28%
|
$558,800
$11.49 P/Share
|
|
Apr 10
2025
|
Christopher Richard Anzalone Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.24%
|
$500,000
$10.87 P/Share
|
|
Apr 09
2025
|
Christopher Richard Anzalone Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,322
-0.33%
|
$403,220
$10.81 P/Share
|